SodiumGlucose Cotransporter Inhibitors Function of SodiumGlucose Cotransporters in the Human Body Sodiumglucose cotransporter-2 (SGLT2) is a high-capacity, low-affinity transporter located solely in the luminal membrane of the S1 and S2 segments of the proximal convoluted tubule of nephrons, and they are responsible for about 90% of renal glucose reabsorption
84 Prepping ingredients in advance (e.g., washing/chopping vegetables, cooking grains)
For moderate or severe sleep apnea, the more substantial weight loss from Retatrutide or Tirzepatide will likely produce better outcomes despite slightly more adjustment challenges
This reflects the state of play as of early 2026: States that cover GLP-1s for obesity treatment (fee-for-service): Arkansas, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Minnesota, New Mexico, New York, Oregon, Virginia, Washington approximately 13 states total as of January 2026
In the four years since that piece, Id say I was 90% correct telehealth is indeed a commodity
The answer goes beyond weight loss, though this is one of the effects that these drugs may produce